Botanical species · safety record

Stachytarpheta jamaicensis

The EFSA Compendium of Botanicals holds 3 constituent measurements and 2 adverse-effect records for Stachytarpheta jamaicensis. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Stachytarpheta jamaicensis (L.) Vahl

3Constituent measurements

2Safety records

4Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Alkaloids	Leaves	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Saponins	Leaves	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Tannins	Leaves	Solvent extraction	—	Phytochemical screening	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Neurotoxicity	Neurologic: central nervous system	Flower	Solvent extraction	Rat (as animal)	Subchronic	No resolvable identifier
Neurotoxicity	Neurologic: central nervous system	Roots and other underground parts	Solvent extraction	Rat (as animal)	Subchronic	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Garc�a-Gonz�lez, Mildred., Coto-Morales, Teresita., Gonz�lez-Camacho, Sara., Pazos, Liliana. Toxicidad subcr�nica del extracto acuoso de las hojas y los brotes florales de Stachytarpheta jamaicensis (L.) Vahl. (Verbenaceae) . Revista cubana de plantas medicinales, 2002, vol. 7, no. 2, p. 0-0.
Parra, AL., Yhebra, RS., Sardinas, IG., Buela, LI. Comparative study of the assay of Artemia salina L. and the estimate of the medium lethal dose (LD50 value) in mice, to determine oral acute toxicity of plant extracts. PHYTOMEDICINE, 2001, vol. 8, no. 5, p. 395-400.
Sivaranjani, R., Ramakrishnan, K., Bhuvaneswari, G. Morpho-anatomical and preliminary phytochemical studies of the leaf of Stachytarpheta jamaicensis (L) Vahl. International journal of pharmtech research, 2013, vol. 5, no. 2, p. 577-582.
Ataman, J.E., Idu, M., Odia, E.A., Omogbai, E.K.I., Amaechina, F., Akhigbe, A.O., Ebite, L.E. Histopathologic effects of Stachytarpheta jamaicensis (L.) Vahl. on Wistar rats. Pakistan journal of biological sciences, 2006, vol. 9, no. 3, p. 477-482. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature